Catherine Johanet

3.8k total citations
105 papers, 2.5k citations indexed

About

Catherine Johanet is a scholar working on Hepatology, Epidemiology and Rheumatology. According to data from OpenAlex, Catherine Johanet has authored 105 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Hepatology, 57 papers in Epidemiology and 29 papers in Rheumatology. Recurrent topics in Catherine Johanet's work include Liver Diseases and Immunity (58 papers), Liver Disease Diagnosis and Treatment (42 papers) and Systemic Lupus Erythematosus Research (27 papers). Catherine Johanet is often cited by papers focused on Liver Diseases and Immunity (58 papers), Liver Disease Diagnosis and Treatment (42 papers) and Systemic Lupus Erythematosus Research (27 papers). Catherine Johanet collaborates with scholars based in France, Italy and United States. Catherine Johanet's co-authors include Éric Ballot, Olivier Chazouillères, Christophe Corpechot, Raoul Poupon, Yves Chrétien, N Abuaf, Ludovico Abenavoli, Tony Andréani, Jean‐Claude Homberg and Laurence Dubel and has published in prestigious journals such as PLoS ONE, Hepatology and Annals of the New York Academy of Sciences.

In The Last Decade

Catherine Johanet

104 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catherine Johanet France 28 1.6k 1.5k 733 614 315 105 2.5k
Paolo Muratori Italy 33 2.1k 1.3× 2.0k 1.4× 854 1.2× 633 1.0× 232 0.7× 76 2.7k
F. Cassani Italy 36 2.4k 1.5× 2.2k 1.5× 682 0.9× 881 1.4× 181 0.6× 72 3.0k
Zakera Shums United States 25 674 0.4× 704 0.5× 414 0.6× 577 0.9× 233 0.7× 57 1.6k
Marshall Kaplan United States 19 1.5k 0.9× 1.2k 0.8× 707 1.0× 277 0.5× 369 1.2× 33 2.1k
J Larrauri Spain 19 434 0.3× 436 0.3× 679 0.9× 276 0.4× 120 0.4× 59 1.5k
Yoshiiku Kawakami Japan 30 1.9k 1.2× 1.5k 1.0× 488 0.7× 132 0.2× 57 0.2× 105 2.6k
Kazuyoshi Katayanagi Japan 21 379 0.2× 977 0.7× 1.6k 2.1× 1.2k 1.9× 54 0.2× 53 2.4k
Dominique Cazals‐Hatem France 19 440 0.3× 337 0.2× 696 0.9× 236 0.4× 112 0.4× 49 1.7k
Ryan M. Gill United States 26 525 0.3× 1.1k 0.7× 440 0.6× 106 0.2× 123 0.4× 73 2.1k
Werner Van Steenbergen Belgium 25 927 0.6× 591 0.4× 1.1k 1.6× 57 0.1× 72 0.2× 65 2.0k

Countries citing papers authored by Catherine Johanet

Since Specialization
Citations

This map shows the geographic impact of Catherine Johanet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Johanet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Johanet more than expected).

Fields of papers citing papers by Catherine Johanet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Johanet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Johanet. The network helps show where Catherine Johanet may publish in the future.

Co-authorship network of co-authors of Catherine Johanet

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Johanet. A scholar is included among the top collaborators of Catherine Johanet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Johanet. Catherine Johanet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Plaçais, Léo, Jonathan Cohen, Ludovic Suner, et al.. (2020). Intralipid therapy for unexplained recurrent miscarriage and implantation failure: Case-series and literature review. European Journal of Obstetrics & Gynecology and Reproductive Biology. 252. 100–104. 28 indexed citations
2.
Ghelfenstein-Ferreira, Théo, François Delhommeau, Catherine Johanet, et al.. (2020). Annexin-A5 resistance and non-criteria antibodies for the diagnosis of seronegative antiphospholipid syndrome. Clinical Rheumatology. 39(4). 1167–1171. 9 indexed citations
3.
Estève, Emmanuel, Emmanuelle Plaisier, Catherine Johanet, et al.. (2019). Rituximab in Patients With Phospholipase A2 Receptor–Associated Membranous Nephropathy and Severe CKD. Kidney International Reports. 5(3). 331–338. 28 indexed citations
4.
5.
Maggiore, Giuseppe, Gèrard Socié, Marco Sciveres, et al.. (2016). Seronegative autoimmune hepatitis in children: Spectrum of disorders. Digestive and Liver Disease. 48(7). 785–791. 38 indexed citations
6.
Chantran, Yannick, Éric Ballot, & Catherine Johanet. (2013). Autoantibodies in primary biliary cirrhosis: Antimitochondrial autoantibodies. Clinics and Research in Hepatology and Gastroenterology. 37(4). 431–433. 8 indexed citations
7.
Sebagh, Mylène, M. Castillo‐Rama, Daniel Azoulay, et al.. (2013). Histologic Findings Predictive of a Diagnosis of De novo Autoimmune Hepatitis After Liver Transplantation in Adults. Transplantation. 96(7). 670–678. 18 indexed citations
8.
Chantran, Yannick, Éric Ballot, & Catherine Johanet. (2013). Autoantibodies in primary biliary cirrhosis: Antinuclear envelope autoantibodies. Clinics and Research in Hepatology and Gastroenterology. 38(3). 256–258. 3 indexed citations
9.
Tolédano, C., A. Kettaneh, Bruno Baudin, et al.. (2012). Aldolase predicts subsequent myopathy occurrence in systemic sclerosis. Arthritis Research & Therapy. 14(3). R152–R152. 21 indexed citations
10.
Ballot, Éric, et al.. (2012). Antineutrophil cytoplasmic auto-antibodies (ANCA) in autoimmune hepatitis and primary sclerosing cholangitis. Clinics and Research in Hepatology and Gastroenterology. 37(1). 105–107. 11 indexed citations
11.
Johanet, Catherine & Éric Ballot. (2011). Auto-antibodies in autoimmune hepatitis: Anti-smooth muscle antibodies (ASMA). Clinics and Research in Hepatology and Gastroenterology. 36(2). 189–191. 7 indexed citations
12.
Naour, François Le, Stéphanie Huguet, René Lai–Kuen, et al.. (2008). Identification of plasma membrane autoantigens in autoimmune hepatitis type 1 using a proteomics tool. Hepatology. 47(3). 937–948. 31 indexed citations
13.
Duclos‐Vallée, Jean‐Charles, Funda Yılmaz, Catherine Johanet, et al.. (2005). Could post‐liver transplantation course be helpful for the diagnosis of so called cryptogenic cirrhosis?. Clinical Transplantation. 19(5). 591–599. 21 indexed citations
14.
Michel, Marc, Catherine Johanet, Olivier Meyer, et al.. (2001). Familial Lupus Erythematosus. Medicine. 80(3). 153–158. 66 indexed citations
15.
Peoc’h, Katell, et al.. (2001). Polyspecificity of antimicrosomal thyroid antibodies in hepatitis C virus-related infection. The American Journal of Gastroenterology. 96(10). 2978–2983. 7 indexed citations
16.
Hurtova, Monika, Jean‐Charles Duclos‐Vallée, Catherine Johanet, et al.. (2001). Successful tacrolimus therapy for a severe recurrence of type 1 autoimmune hepatitis in a liver graft recipient. Liver Transplantation. 7(6). 556–558. 39 indexed citations
17.
Abuaf, N, Syria Laperche, Olivier Meyer, et al.. (1995). Antimitochondrial antibodies in the antiphospholipid syndrome. Clinical Reviews in Allergy & Immunology. 13(1). 57–65. 1 indexed citations
18.
19.
Chrétien, Pascale, et al.. (1994). [Comparison of indirect immunofluorescence on Crithidia luciliae of Farr test, and immunoenzymatic methods for the screening of anti-native DNA autoantibodies].. PubMed. 52(9). 645–50. 4 indexed citations
20.
Martini, E., N Abuaf, Florence M.G. Cavalli, et al.. (1988). Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2. Hepatology. 8(6). 1662–1666. 160 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paolo Muratori Breakdown of academic impact, for papers by F. Cassani Breakdown of academic impact, for papers by Zakera Shums Breakdown of academic impact, for papers by Marshall Kaplan Breakdown of academic impact, for papers by J Larrauri Breakdown of academic impact, for papers by Yoshiiku Kawakami Breakdown of academic impact, for papers by Kazuyoshi Katayanagi Breakdown of academic impact, for papers by Dominique Cazals‐Hatem Breakdown of academic impact, for papers by Ryan M. Gill Breakdown of academic impact, for papers by Werner Van Steenbergen
Rankless by CCL
2026